MOUNT SINAI MEDICAL CENTER has a total of 12 patent applications. Its first patent ever was published in 1991. It filed its patents most often in Australia, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are REPROGEN INC, UNIV DE SALAMANCA O T R I and BORLAK JUERGEN.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Israel | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Agriculture | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Measuring microorganism processes | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Therapeutic chemical compounds | |
#7 | Animal care | |
#8 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Palese Peter | 5 |
#2 | O'Neill Robert | 5 |
#3 | Desnick Robert J | 3 |
#4 | Sandrin Mauro S | 2 |
#5 | Mckenzie Ian F C | 2 |
#6 | Ioannou Yiannis | 2 |
#7 | Haber Richard S | 1 |
#8 | Burstein David E | 1 |
#9 | Wetmur James G | 1 |
#10 | Schuchman Edward H | 1 |
Publication | Filing date | Title |
---|---|---|
US5897991A | Highly sensitive immunocytochemical method for diagnosis of malignant effusions | |
IL124293D0 | Method and compositions for the reduction of xenotransplantation rejection | |
CA2234047A1 | Antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for replication | |
AU3953895A | Antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for replication | |
US5750394A | Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication | |
US5773278A | Acid sphingomyelinase gene |